NCT00748813

Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2008/2009

A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine, Formulation 2008-2009, When Administered to Non-Elderly Adult and Elderly Sub

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 133 (actual)
• Sponsor: Novartis Vaccines · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

Annual trial for registration influenza vaccine with the strain composition for season 2008/2009

Conditions

• Seasonal Influenza

Interventions

Type	Name	Description
BIOLOGICAL	Influenza Vaccine, Formulation 2008-2009	1 dose of Surface Antigen, Inactivated, Influenza Vaccine, Formulation 2008-2009

Timeline

• Start date: 2008-06-01
• Primary completion: 2008-07-01
• Completion: 2008-07-01
• First posted: 2008-09-09
• Last updated: 2016-12-01

Locations

3 sites across 1 country: Italy